Closed · DE-FOA-0002532 · CFDA 81.049 · Discretionary

Advancing Novel Medical Isotopes for Clinical Trials

Federal grant opportunity posted by Office of Science, cataloged on Grants.gov.

$100K-$500K
Award range
Closed
Status
July 23, 2021
Close date
-
Expected awards

The verdict

Advancing Novel Medical Isotopes for Clinical Trials is a closed discretionary listing from Office of Science that offered $100,000 -- $500,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 414 other opportunities from Office of Science.

$100K-$500K
award range
Closed
application status
81.049
CFDA program
414
other opportunities from Office of Science

Archived opportunity record

Advancing Novel Medical Isotopes for Clinical… is closed (last close July 23, 2021). The parent program page for CFDA 81.049 is the reliable place to catch re-announcements. Office of Science still indexes 414 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed July 23, 2021

Posted Jun 1 Closes Jul 23

Instrument

Grant

Description

The DOE SC program in Isotope R&D and Production (DOE IP) hereby announces its interest in receiving applications for research to facilitate, streamline, and accelerate the translation of novel radioisotopes and their associated chelating agents and linker/ligands, for both diagnosis and treatment, from the laboratory bench to evaluation for potential usage in clinical and pre-clinical trials. Evaluating these materials for use in clinical and pre-clinical trials is beyond the scope of this FOA as well as outside the mission of the DOE IP: Applications requesting support for such evaluations will be declined without merit review. Successful applications would benefit the public by leveraging the scientific and technical capabilities of existing facilities at institutions of higher education, non-profit research institutions, and DOE/National Nuclear Security Administration (NNSA) National Laboratories to accelerate the development process for new diagnostic and therapeutic agents. Applications focused on aspects of isotope R&D not associated with translational research are outside the scope of this FOA and will be declined without merit review. Applications are restricted to recently-developed medical isotopes by the DOE IP (listed on the next page) but are not restricted in chelator/ligand technology. Applications incorporating effective ways to train personnel with essential knowledge and skills related to the production, processing, purification, and distribution of enriched stable and radioactive isotopes are strongly encouraged. While this FOA is administered by the DOE IP, the assessment of submitted proposals will be in coordination with the National Institutes of Health.

Multi-door applicant board · 3 Grants.gov types

Grants.gov prints 3 distinct applicant types for Advancing Novel Medical Isotopes for Clinical… (Public / state-controlled institutions of higher education; Private institutions of higher education; Others (see official listing text)). Filter fit against the official announcement before drafting. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). Only 4 other Office of Science listings share this exact eligibility-code string (1% of 415).

Code 06
Public / state-controlled institutions of higher education
Code 20
Private institutions of higher education
Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Parent Grant Program

CFDA 81.049

Basic Energy Sciences

U.S. Department of Energy

View program →

Agency Contact

Ethan Balkin, Ph.D. Program Manger Phone 301-903-1861

More from Office of Science

Open Closes December 17, 2026

The Genesis Mission: Transforming Science and Energy with AI

View →
Closed Closed September 30, 2026

FY 2026 Continuation of Solicitation for the Office of Science Financial Assistance Program

View →

What to do next

Advancing Novel Medical Isotopes for Clinical… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 81.049 may publish future NOFOs under the same assistance listing. Open program
  • Basic Energy Sciences indexes 6 Grants.gov listings in this extract. Program profile
  • Office of Science lists 414 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants